Wird geladen...
Predictive biomarkers for tumor immune checkpoint blockade
The development of immune checkpoint inhibitors represented by PD-1 and PD-L1 has provided new hope for the treatment of advanced cancer patients. However, there are no effective predictive biomarkers, which have caused many limitations to the clinical application of immune checkpoint inhibitors. Th...
Gespeichert in:
| Veröffentlicht in: | Cancer Manag Res |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6190817/ https://ncbi.nlm.nih.gov/pubmed/30349382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S179680 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|